smartdyelivery

  

est. 2014

Our Vision

" Magical spheres " for the therapy of diseases

Our Vision

„We must learn to create magical spheres that ... only hit the pathogens.”

Paul Ehrlich 1854-1915

With tailor-made nanocarriers, we will set new standards for the targeted, efficient and low-risk use of active pharmaceutical ingredients and other highly potent substances for medical and life science applications.

NEWS

November 18, 2019

SMARTDYELIVERY AT THE LONG NIGHT OF THE SCIENCES: On Friday, November 22, the Long Night of the Sciences takes place from 6 to 12 pm in Jena. We are prepared: If you want to learn more about "smart" nanocarriers, visit us at the Center for Applied Research, Philosophenweg 7. At our booth you can formulate "smart particles" yourself and playfully bring particles into the liver!

October 31, 2019

PRIZE FOR YOUNG SCIENTIST: Congratulations to our co-founder, Dr. Anja Träger, for receiving a Young Scientist Award from the Macromolecular Chemistry Section of the German Chemical Society (Gesellschaft Deutscher Chemiker e.V.). (GDCh)! Dr. Träger leads a working group at the Jena Center for Soft Matter (JCSM) of the University of Jena and has supported SmartDyeLivery since the beginning with her expertise in the field of complex polymer nanostructures.

September 16, 2019

SMARTDYELIVERY AT THE CONGRESS OF THE GERMAN SEPSIS-SOCIETY: Sepsis experts from all over the world discussed current developments in intensive care medicine at the Sepsis Update, which took place last week in Weimar. Our co-founder Prof. Michael Bauer, Director of the Clinic for Anaesthesiology and Intensive Care at the University Hospital of Jena and spokesman for the Center for Sepsis Control & Care (CSCC), reported on the current therapy and future medical requirements for septic liver failure. The SmartDyeLivery team heard the latest findings from sepsis research.

DEVELOPMENT OF NEW THERAPY OPTIONS

In a first field of application we focus on the targeted transport of active substances in liver cells. We are thus creating a therapeutic option for the treatment of patients with septic cholestasis with the aim of reducing the extremely high mortality rate caused by this complication.

CONTACT

Email

This email address is being protected from spambots. You need JavaScript enabled to view it.

This email address is being protected from spambots. You need JavaScript enabled to view it.

Botzstraße 5 | 07743 Jena Germany

 

Visitor Adress:

Philosophenweg 7a | 07743 Jena Germany

Funding

             INVEST Logo URL rote URL RZ quadr2
         
 
 
TAB

 

zim 4c klein

Copyright © 2015 - 2018 redcat DESIGNGROUP